TransMedics Group (TMDX) News Today → Kiss of death from Joe Biden (From Porter & Company) (Ad) Free TMDX Stock Alerts $136.40 -0.02 (-0.01%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 1 at 9:22 AM | insidertrades.comDavid Weill Sells 1,193 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) StockJune 1 at 8:48 AM | marketbeat.comAxiom Investors LLC DE Has $6.61 Million Position in TransMedics Group, Inc. (NASDAQ:TMDX)Axiom Investors LLC DE lifted its holdings in TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) by 83.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 83,750 shares of the company's stock afterMay 31 at 4:43 PM | marketbeat.comTransMedics Group, Inc. (NASDAQ:TMDX) Director Sells $168,988.45 in StockTransMedics Group, Inc. (NASDAQ:TMDX - Get Free Report) Director David Weill sold 1,193 shares of the company's stock in a transaction that occurred on Wednesday, May 29th. The shares were sold at an average price of $141.65, for a total value of $168,988.45. Following the completion of the sale, the director now owns 10,732 shares of the company's stock, valued at $1,520,187.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.May 29 at 5:12 AM | marketbeat.comBNP Paribas Financial Markets Sells 12,014 Shares of TransMedics Group, Inc. (NASDAQ:TMDX)BNP Paribas Financial Markets lowered its position in TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) by 48.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 12,872 shares of the company's stock afterMay 28, 2024 | marketbeat.comTransMedics Group (NASDAQ:TMDX) Hits New 52-Week High at $143.46TransMedics Group (NASDAQ:TMDX) Reaches New 12-Month High at $143.46May 26, 2024 | marketbeat.comTransMedics Group, Inc. (NASDAQ:TMDX) Shares Sold by Victory Capital Management Inc.Victory Capital Management Inc. trimmed its position in TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) by 59.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,239 shares of the companMay 25, 2024 | americanbankingnews.comAVITA Medical (NASDAQ:RCEL) and TransMedics Group (NASDAQ:TMDX) Critical SurveyMay 23, 2024 | marketbeat.comJump Financial LLC Reduces Position in TransMedics Group, Inc. (NASDAQ:TMDX)Jump Financial LLC trimmed its stake in TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) by 91.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,300 shares of the company's stock after selling 70,459May 22, 2024 | marketbeat.comDynamic Technology Lab Private Ltd Invests $889,000 in TransMedics Group, Inc. (NASDAQ:TMDX)Dynamic Technology Lab Private Ltd purchased a new stake in TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 11,263 shares of the company's stock, valued at approximately $8May 21, 2024 | seekingalpha.comTransMedics: Transportation Supporting GrowthMay 20, 2024 | marketbeat.comTransMedics Group (NASDAQ:TMDX) Sets New 1-Year High at $140.26TransMedics Group (NASDAQ:TMDX) Sets New 52-Week High at $140.26May 18, 2024 | marketbeat.comSwiss National Bank Trims Stock Holdings in TransMedics Group, Inc. (NASDAQ:TMDX)Swiss National Bank lessened its holdings in shares of TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) by 10.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 64,300 shares of the compaMay 17, 2024 | prnewswire.comTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)May 15, 2024 | marketbeat.comTransMedics Group, Inc. (NASDAQ:TMDX) Shares Sold by Nicholas Investment Partners LPNicholas Investment Partners LP trimmed its position in shares of TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) by 85.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 58,498 shares oMay 15, 2024 | insidertrades.comInsider Selling: TransMedics Group, Inc. (NASDAQ:TMDX) Director Sells 2,500 Shares of StockMay 14, 2024 | marketbeat.comTransMedics Group (NASDAQ:TMDX) Sets New 52-Week High at $137.22TransMedics Group (NASDAQ:TMDX) Reaches New 52-Week High at $137.22May 9, 2024 | insidertrades.comInsider Selling: TransMedics Group, Inc. (NASDAQ:TMDX) Insider Sells 3,222 Shares of StockMay 9, 2024 | insidertrades.comTransMedics Group, Inc. (NASDAQ:TMDX) CEO Sells $3,902,100.00 in StockMay 9, 2024 | finance.yahoo.comInsider Sale: Director Edward Basile Sells Shares of TransMedics Group Inc (TMDX)May 8, 2024 | insidertrades.comTransMedics Group, Inc. (NASDAQ:TMDX) Director James R. Tobin Sells 12,025 SharesMay 7, 2024 | marketbeat.comInsider Selling: TransMedics Group, Inc. (NASDAQ:TMDX) Director Sells 12,025 Shares of StockTransMedics Group, Inc. (NASDAQ:TMDX - Get Free Report) Director James R. Tobin sold 12,025 shares of TransMedics Group stock in a transaction on Friday, May 3rd. The stock was sold at an average price of $125.05, for a total transaction of $1,503,726.25. Following the completion of the sale, the director now owns 193,146 shares of the company's stock, valued at approximately $24,152,907.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.May 7, 2024 | marketbeat.comTransMedics Group (NASDAQ:TMDX) Reaches New 52-Week High at $132.96TransMedics Group (NASDAQ:TMDX) Reaches New 1-Year High at $132.96May 6, 2024 | marketbeat.comLisanti Capital Growth LLC Takes Position in TransMedics Group, Inc. (NASDAQ:TMDX)Lisanti Capital Growth LLC acquired a new position in TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 109,435 shares of the company's stMay 6, 2024 | seekingalpha.comTransMedics Group: Looking At The Road Ahead After An Exceptional Q1 (Rating Downgrade)May 5, 2024 | finance.yahoo.comTransMedics Group, Inc. (NASDAQ:TMDX) Q1 2024 Earnings Call TranscriptMay 4, 2024 | insidertrades.comInsider Selling: TransMedics Group, Inc. (NASDAQ:TMDX) Director Sells 15,040 Shares of StockMay 4, 2024 | insidertrades.comInsider Selling: TransMedics Group, Inc. (NASDAQ:TMDX) CEO Sells 56,000 Shares of StockMay 4, 2024 | marketbeat.comNew York State Common Retirement Fund Increases Stock Holdings in TransMedics Group, Inc. (NASDAQ:TMDX)New York State Common Retirement Fund grew its holdings in shares of TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) by 41.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 87,516 shares of the company'sMay 3, 2024 | finance.yahoo.comTransMedics Group First Quarter 2024 Earnings: Beats ExpectationsMay 3, 2024 | finance.yahoo.comShould You Think About Buying TransMedics Group, Inc. (NASDAQ:TMDX) Now?May 3, 2024 | marketbeat.comWilliam Blair Analysts Increase Earnings Estimates for TransMedics Group, Inc. (NASDAQ:TMDX)TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) - Equities researchers at William Blair upped their Q2 2024 earnings per share estimates for shares of TransMedics Group in a research note issued to investors on Tuesday, April 30th. William Blair analyst R. Daniels now expects that the companyMay 2, 2024 | marketbeat.comTransMedics Group, Inc. (NASDAQ:TMDX) to Post Q3 2025 Earnings of $0.12 Per Share, William Blair ForecastsTransMedics Group, Inc. (NASDAQ:TMDX - Free Report) - William Blair lifted their Q3 2025 earnings per share estimates for shares of TransMedics Group in a report issued on Tuesday, April 30th. William Blair analyst R. Daniels now anticipates that the company will post earnings per share of $0.12May 1, 2024 | wsj.comTransMedics Group Inc.May 1, 2024 | fool.comWhy TransMedics Stock Is Soaring TodayMay 1, 2024 | marketbeat.comTransMedics Group (NASDAQ:TMDX) PT Raised to $130.00TD Cowen increased their price objective on TransMedics Group from $100.00 to $130.00 and gave the stock a "buy" rating in a report on Wednesday.May 1, 2024 | msn.comCrude Oil Down 3%; ISM Manufacturing PMI Falls In AprilMay 1, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY), TransMedics Group (TMDX) and Incyte (INCY)May 1, 2024 | markets.businessinsider.comTransMedics Stock Skyrockets, Analysts Call It 'One Of The Best Organic Growth Stories'May 1, 2024 | marketbeat.comTransMedics Group (NASDAQ:TMDX) Sets New 52-Week High After Strong EarningsTransMedics Group (NASDAQ:TMDX) Reaches New 1-Year High on Better-Than-Expected EarningsMay 1, 2024 | marketbeat.comTransMedics Group's (TMDX) "Overweight" Rating Reaffirmed at Piper SandlerPiper Sandler restated an "overweight" rating and issued a $120.00 target price (up previously from $95.00) on shares of TransMedics Group in a report on Wednesday.May 1, 2024 | marketbeat.comTransMedics Group (NASDAQ:TMDX) Releases Earnings Results, Beats Estimates By $0.40 EPSTransMedics Group (NASDAQ:TMDX - Get Free Report) issued its quarterly earnings data on Tuesday. The company reported $0.35 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.05) by $0.40. TransMedics Group had a negative return on equity of 2.35% and a negative net margin of 10.36%. The firm had revenue of $96.90 million during the quarter, compared to the consensus estimate of $83.78 million. During the same period in the previous year, the firm posted ($0.08) EPS. The company's quarterly revenue was up 132.9% compared to the same quarter last year.May 1, 2024 | finance.yahoo.comTransMedics Group Inc (TMDX) Q1 2024 Earnings Call Transcript Highlights: Soaring Revenues and ...May 1, 2024 | finance.yahoo.comQ1 2024 Transmedics Group Inc Earnings CallApril 30, 2024 | sfgate.comTransMedics: Q1 Earnings SnapshotApril 30, 2024 | finance.yahoo.comTransMedics Group Inc (TMDX) Surpasses Analyst Revenue Forecasts with Stellar Q1 2024 ResultsApril 30, 2024 | prnewswire.comTransMedics Reports First Quarter 2024 Financial ResultsApril 29, 2024 | markets.businessinsider.comHere's what Wall Street expects from TransMedics Group's earnings reportApril 25, 2024 | marketbeat.comTransMedics Group, Inc. (NASDAQ:TMDX) Holdings Lifted by Sandhill Capital Partners LLCSandhill Capital Partners LLC grew its position in shares of TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) by 4.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 763,201 shares of the company's stock after buyinApril 24, 2024 | marketbeat.comTransMedics Group, Inc. (NASDAQ:TMDX) Shares Sold by J.W. Cole Advisors Inc.J.W. Cole Advisors Inc. lowered its stake in shares of TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) by 61.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,526 shares of thApril 23, 2024 | marketbeat.comTransMedics Group (TMDX) Scheduled to Post Quarterly Earnings on TuesdayTransMedics Group (NASDAQ:TMDX) will be releasing earnings after the market closes on Tuesday, April 30, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=585292) Get TransMedics Group News Delivered to You Automatically Sign up to receive the latest news and ratings for TMDX and its competitors with MarketBeat's FREE daily newsletter. Email Address “This will be one of the biggest revolutions ever.” - NVIDIA CEO (Ad)NVIDIA's CEO calls it the "next amazing revolution"... The Economist says its a "boon to humanity"... And Jeff Bezos is heavily invested in it. A new breakthrough tech could add up to $20 trillion to the U.S. economy. TMDX Media Mentions By Week TMDX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TMDX News Sentiment▼0.430.78▲Average Medical News Sentiment TMDX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TMDX Articles This Week▼95▲TMDX Articles Average Week Get TransMedics Group News Delivered to You Automatically Sign up to receive the latest news and ratings for TMDX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Integer News LivaNova News Masimo News CONMED News InMode News Soleno Therapeutics News Inspire Medical Systems News CRISPR Therapeutics News Nuvalent News Alpine Immune Sciences News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TMDX) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TransMedics Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
